Furthermore, most patients with primary choriocarcinoma of the stomach do not survive for even 1 year after operation, so the prognosis is considerably worse than that of common gastric adenocarcinoma. We report a patient with primary choriocarcinoma of the stomach who received a correct diagnosis preoperatively and who survived for 4 years and 6 months after operation.
Case report
A 68-year-old Japanese man was referred to the Second Department of Surgery at Oita Medical University, on April 12, 1994 . He had been suffering for 1 month from epigastric pain, abdominal fullness, and dizziness. His only significant past medical history was hypertension, requiring treatment with a calcium channel blocker. He had three healthy children. The family history was essentially negative for familial or hereditary disease, but his elder brother had died of gastric cancer.
On examination, the patient was pale because of severe anemia, and had an ill-defined mobile epigastric mass, approximately 5 cm by 10cm in size. Supraclavicular lymph nodes were not palpable, and the testes and breasts were normal. Initial laboratory study results were normal, except for hemoglobin, at 8.7g/dl, and a hematocrit of 26.6% (Table 1) . Radiographic examination of the upper gastrointestinal tract demonstrated a large tumor in the gastric body and antrum with an annular stricture. There were scirrhous changes of the gastric wall and an absence of gastric folds, thus raising a suspicion of Borrmann type IV cancer. As to tumor markers, serum carcinoembryonic antigen (CEA), alpha-fetoprotein (AFP), and carbohydrate antigen (CA)-19-9 levels were within normal limits. Gastric fiberscopy revealed a large tumor occupying the gastric body and antrum, with a mixture of protruding and ulcerative lesions, accompanied by areas of hemorrhage.
Introduction
Choriocarcinoma is a rapidly growing and widely metastatic epithelial neoplasm, derived from either trophoblastic or totipotential germ cells [1] . In most cases, the tumor arises from chorionic villi in association with normal and abnormal gestation [2] , including ectopic pregnancy [3] . Choriocarcinoma may also occur as a primary neoplasm of the ovary [4] or testis [5] . Primary choriocarcinoma of the stomach is extremely rare, and most such cases are not diagnosed correctly before operation.
Biopsy specimens were interpreted as showing adenocarcinoma with choriocarcinomatous differentiation, using hematoxylin and eosin (H&E) staining and immunohistochemistry (Fig. 1a,b) . Levels of human chorionic gonadtropin ([hCG]-enzyme immunoassay [EIA]) and its beta-subunit (hCG-) in the serum and in the urine were extremely high (Table  1) .
Operative findings (according to the Japanese classification of gastric carcinoma, 2nd English edition) [6] The patient underwent total gastrectomy on April 20, 1994 , with the preoperative diagnosis of primary gastric choriocarcinoma. Liver metastasis, peritoneal dissemination, and ascites were not investigated (H0, P0), and distant metastasis to other organs was not present (M0).
There was an invasive tumor encircling the gastric body and antrum. Macroscopic lymph node metastasis was seen at the following lymph nodes (LN): right paracardial (no. 1); LN along the lesser curvature (no. 3); suprapyloric LN (no. 5); infrapyloric LN (no. 6); LN along the left gastric artery (no. 7); and LN along the common hepatic artery (no. 8a) (N3). These lymph nodes were connected with each other, forming a nodular mass and infiltrating to the pancreas (T4). The operative staging group was stage IVb (H0P0N3T4M0). Total gastrectomy with D3 lymph node dissection (nos. 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14) , cholecystectomy, and splenectomy were performed, and the lesion of lymph nodes infiltrating the pancreas was removed using an electric knife. The Roux-en-Y method of reconstruction was performed after resection. At the conclusion of surgery, the curative potential of resection was "resection B"; namely, definite residual disease was not present. GOT 20.9 IU/l rGTP 11.7 IU/l Plt 36.7 ϫ 10 4 /µl GPT 12.6 IU/l CHOL 125 g/dl AMY 51 U/l BUN 11.7 mg/dl CRNN 1.00 mg/dl CEA 1.1 ng/ml (normal, Ͻ5 ng/ml) CA19-9 12.6 U/ml (normal, Ͻ36.4 U/ml) AFP 0.8 ng/ml (normal, 0-20 ng/ml) Serum hCG 140 ng/ml (normal, Ͻ0.1 ng/ml) Serum hCG-EIA 8100 mIU/ml (normal, Ͻ0.7 mIU/ml) Urine hCG 55 ng/ml (normal, Ͻ0.1 ng/ml) hCG, Human chorionic gonadotropin; EIA, enzyme immunoassay 
Pathological findings
The tumor was 10cm by 12 cm in size, irregularly shaped but relatively limited to the body and prepylorus of the stomach. Almost half of the tumor demonstrated villous growth, with some bleeding areas (Fig. 2) .
Under low magnification with H&E staining, cell proliferation demonstrated a sheet-like appearance, with many foci of hemorrhage and necrosis being observed. Under high magnification (Fig. 3) , tumor cells exhibited two histologic types: "cytotrophoblastic cells", with large, oval nuclei; and "syncytiotrophoblastic cells" with bizzare nuclei. The mixture of these cells was investigated.
Most of the neoplastic cells, especially the syncytiotrophoblastic cells, showed strong immunohistochemical staining against anti-hCG (α and ). The metastatic cells in the lymph nodes were stained similarly.
Histologically, tubulo-papillary adenocarcinoma was also seen in some areas, although most of the tumor was choriocarcinoma, which demonstrated strong reactivity against anti-hCG antibody. These two types of carcinomas were closely adjoining each other (Fig. 4a) . We could easily recognize the borderline between the choriocarcinomatous and adenocarcinomatous components by immunohistochemical staining, using anti CEA antibody, as the adenocarcinoma stained positively, but the choriocarcinoma did not (Fig. 4b) .
Postoperative course (Fig. 5) Postoperative chemotherapy was performed, employing the same regimen as that used for advanced gastric adenocarcinoma at our department. Intravenous injections of mitomycin C (MMC) were given as 20mg on the day of operation and 10mg on the next day. The subsequent treatment consisted of three cycles of 5-fluorouracil (5-FU) and cisplatin (CDDP), given once a month. Each treatment cycle included 5-FU 750mg/day on days 1 to 5, as a 24-h continuous drip infusion, and CDDP 75mg/day on day 1, as a 5-h drip infusion. After the three cycles of CDDP and 5-FU, the patient received uracil and futrafur (UFT) orally. The dose of UFT was 600mg/day. No side effects, other than leukopenia, were seen during the chemotherapy over a period of 27 months.
The patient came to see us monthly. Serum hCG, which we employed as a tumor marker, was measured at each visit. No re-elevation of serum hCG was ever seen and no liver or lymph node metastases were detected on thoraco-abdominal computed tomography scans.
The patient ultimately died of restrictive lung disease 4 years and 6 months after the surgery. 
Discussion
Choriocarcinoma can be gonadal or extragonadal in origin, and occurs most frequently in the uterus in association with pregnancy. The most common sites for extragonadal tumors are the mediastinum [7] , ovary [4] and testis [5] . Primary choriocarcinoma of the stomach is extremely rare, although metastatic choriocarcinoma to the stomach has been reported numerous Krulewski (1988) [22] 62, M Adenocarcinoma Yes Yes 9 Months Matsunage (1989) [23] 58, F No Not mentioned No (autopsy) Refractory Gorczyca (1992) [24] 71, F Adenocarcinoma No Yes Not mentioned Motoyama (1994) [25] 46, F No Yes Yes 12 Months Imai (1994) [26] 63, M Adenocarcinoma Yes Yes 88 Days Bateman (1995) [27] 80, M Undifferentiated ca. Not mentioned No 4 Months Jan (1997) [28] 71, F No Yes Yes 23 Days Coskum (1998) [29] 37, F Chorioca. Preoperative diagnosis: yes, Choriocarcinoma; no, biopsy was not done; coexistence: yes, coexistent with common adenocarcinoma (adenoca.); no, choriocarcinoma (chorioca.) only; diff., differentiated times [8] [9] [10] . To date, about 40 cases of primary choriocarcinoma of the stomach have been reported in the English-language literature, following the first descriptions by Davidsohn (in German) [11] and Helmholz [12] . We reviewed 19 cases reported in the Englishlanguage literature after 1980 (Table 2 ) [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] . The mean age of the patients was 55 years, ranging from 23 to 80 years. Nine patients were male and ten were female. We describe here a well-documented case of primary gastric choriocarcinoma, as supported by the following evidence. First, no cancer lesions were found elsewhere in the patient besides the stomach. Second, the tumor histology itself was that of choriocarcinoma in all sites, showing immunohistochemical positivity of the tumor cells against hCG antibody. Finally, extremely high levels of serum hCG and urine hCG were detected preoperatively, but these levels decreased to within normal limits after total gastrectomy and chemotherapy.
There are several theories of the histopathogenesis of primary gastric choriocarcinoma. These hypotheses include; histological resemblance to choriocarcinoma [30] , origin from a gonadal anlage displaced in the abdomen [11] , presence as a long-delayed metastasis from a genital primary lesion [31] , origin from an underlying gastric teratoma [32] , and the retrodifferentiation or opisthoplasia of carcinoma cells to the level of the embryonal ectoderm with the ability to form trophoblasts [33] . In support of the retrodifferentiation theory are the findings that gastric choriocarcinomas are frequently accompanied by adenocarcinoma or other elements, and occasionally show a transitional form between adenocarcinoma and choriocarcinoma. In addition, gastric choriocarcinoma shows a similarity to gastric adenocarcinoma in age and sex distributions. For these reasons, several contemporary investigators have accepted the retrodifferentiation theory, which showed a retrodifferentiation of the adenocarcinoma cells to the level of the embryonal ectoderm and, subsequently, a metaplasia or disdifferentiation to trophoblastic precursor cells.
In the present patient, the authors wish to stress two points. First, the tumor was correctly diagnosed before operation by the pathological examination of biopsy specimens, unlike most of the previously reported cases that we reviewed. Of the 19 patients whose cases were reviewed in this report, only 3 patients were correctly diagnosed as having gastric choriocarcinoma. Perhaps clinicians should take more biopsy specimens when encountering large and hemorrhagic tumors, in order to correctly diagnose gastric choriocarcinoma.
Second, our patient survived for 4 years and 6 months after operation. As many case reports mention [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] , primary gastric choriocarcinoma exhibits extremely high malignancy, and most patients die within 1 year after diagnosis. Our patient had a prolonged survival after undergoing gastrectomy followed by a common chemotherapy regimen often employed in gastric adenocarcinoma [34, 35] . The patient ultimately died of lung disease without any re-elevation of serum hCG level. We therefore believe that the patient was cured of his choriocarcinoma.
In conclusion, we treated a patient with primary gastric choriocarcinoma successfully. From this experience, we recommend radical operation and combined chemotherapy for such a carcinoma. There is no established regimen of chemotherapy for primary gastric choriocarcinoma, but we suggest 5-FU and CDDP combination therapy, based on our experience with this patient.
